Efg Asset Management (North America) Corp. Ultragenyx Pharmaceutical Inc. Transaction History
Efg Asset Management (North America) Corp.
- $724 Million
- Q3 2025
A detailed history of Efg Asset Management (North America) Corp. transactions in Ultragenyx Pharmaceutical Inc. stock. As of the latest transaction made, Efg Asset Management (North America) Corp. holds 127,985 shares of RARE stock, worth $4.23 Million. This represents 0.53% of its overall portfolio holdings.
Number of Shares
127,985
Previous 135,850
5.79%
Holding current value
$4.23 Million
Previous $4.94 Million
22.07%
% of portfolio
0.53%
Previous 0.74%
Shares
11 transactions
Others Institutions Holding RARE
# of Institutions
348Shares Held
88.2MCall Options Held
2.19MPut Options Held
1.04M-
Vanguard Group Inc Valley Forge, PA10.1MShares$335 Million0.0% of portfolio
-
Black Rock Inc. New York, NY5.6MShares$185 Million0.01% of portfolio
-
Jpmorgan Chase & CO New York, NY4.01MShares$133 Million0.01% of portfolio
-
Sands Capital Management, LLC Arlington, VA3.77MShares$125 Million0.33% of portfolio
-
State Street Corp Boston, MA3.69MShares$122 Million0.0% of portfolio
About Ultragenyx Pharmaceutical Inc.
- Ticker RARE
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 70,036,896
- Market Cap $2.32B
- Description
- Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in North America, Europe, and internationally. Its biologic products include Crysvita (burosumab), an antibody targeting fibroblast...